nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of anti-MOG antibody-positive unilaterally dominant meningoencephalitis followed by longitudinally extensive transverse myelitis
|
Sugimoto, Takamichi |
|
2018 |
25 |
C |
p. 128-130 |
artikel |
2 |
A contemporary study of mortality in the multiple sclerosis population of south east Wales
|
Harding, Katharine |
|
2018 |
25 |
C |
p. 186-191 |
artikel |
3 |
Adult-onset hemophagocytic lymphohistiocytosis type 2 presenting as a demyelinating disease
|
Algahtani, Hussein |
|
2018 |
25 |
C |
p. 77-82 |
artikel |
4 |
Alemtuzumab-containing reduced intensity conditioning allogenic hematopoietic stem cell transplantation in a case of primary progressive multiple sclerosis
|
AlKhaja, Mohamed |
|
2018 |
25 |
C |
p. 334-336 |
artikel |
5 |
An interesting PRESentation of NMO
|
Klenofsky, B |
|
2018 |
25 |
C |
p. 163-164 |
artikel |
6 |
An MRI evaluation of grey matter damage in African Americans with MS
|
Petracca, Maria |
|
2018 |
25 |
C |
p. 29-36 |
artikel |
7 |
Association between brain atrophy and cognitive motor interference in multiple sclerosis
|
Coghe, Giancarlo |
|
2018 |
25 |
C |
p. 208-211 |
artikel |
8 |
A systematic critical review of physical activity aspects in clinical guidelines for multiple sclerosis
|
Geidl, Wolfgang |
|
2018 |
25 |
C |
p. 200-207 |
artikel |
9 |
Azathioprine-induced pellagra in neuromyelitis optica: A case report and review of literature
|
Zhao, Cong |
|
2018 |
25 |
C |
p. 104-107 |
artikel |
10 |
Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis
|
Bensi, C |
|
2018 |
25 |
C |
p. 246-250 |
artikel |
11 |
Cardiovascular conditions in persons with multiple sclerosis, neuromyelitis optica and transverse myelitis
|
Saroufim, Paola |
|
2018 |
25 |
C |
p. 21-25 |
artikel |
12 |
CLIPPERS syndrome responsive to Leflunomide: A case report
|
Didier, Parada-Garza Juan |
|
2018 |
25 |
C |
p. 265-267 |
artikel |
13 |
Co-ocurrence of neurosarcoidosis and intrathecal reactivation of Epstein-Barr virus
|
Salazar, Richard |
|
2018 |
25 |
C |
p. 297-299 |
artikel |
14 |
Coping strategies and quality of life in Mexican multiple sclerosis patients: Physical, psychological and social factors relationship
|
Hernández-Ledesma, Ana Laura |
|
2018 |
25 |
C |
p. 122-127 |
artikel |
15 |
Decreasing longitudinal use of glucocorticosteroids in multiple sclerosis
|
Ellenberger, David |
|
2018 |
25 |
C |
p. 173-174 |
artikel |
16 |
Development and validation of a multidimensional health literacy questionnaire for multiple sclerosis patients
|
Dehghani, Ali |
|
2018 |
25 |
C |
p. 156-162 |
artikel |
17 |
Dysregulation of long non-coding RNA profile in peripheral blood of multiple sclerosis patients
|
Dastmalchi, Romina |
|
2018 |
25 |
C |
p. 219-226 |
artikel |
18 |
Effects of cigarette smoking on respiratory problems and functional levels in multiple sclerosis patients
|
Aktan, Ridvan |
|
2018 |
25 |
C |
p. 271-275 |
artikel |
19 |
Efficacy and safety of monoclonal antibody therapies for relapsing remitting multiple sclerosis: A network meta-analysis
|
Xu, Xinghua |
|
2018 |
25 |
C |
p. 322-328 |
artikel |
20 |
Epstein Barr virus shedding in multiple sclerosis: Similar frequencies of EBV in saliva across separate patient cohorts
|
Holden, David W |
|
2018 |
25 |
C |
p. 197-199 |
artikel |
21 |
Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria
|
Habek, Mario |
|
2018 |
25 |
C |
p. 99-103 |
artikel |
22 |
Evidence of attentional impairments using virtual driving simulation in multiple sclerosis
|
Harand, C. |
|
2018 |
25 |
C |
p. 251-257 |
artikel |
23 |
Factors associated with perceived need for mental health care in multiple sclerosis
|
Orr, Justine |
|
2018 |
25 |
C |
p. 179-185 |
artikel |
24 |
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis
|
Lavorgna, L. |
|
2018 |
25 |
C |
p. 175-178 |
artikel |
25 |
Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous system
|
Grüter, Thomas |
|
2018 |
25 |
C |
p. 83-86 |
artikel |
26 |
Gynecological adverse effects of natalizumab administration: Case report and review of the literature
|
Makris, Georgios-Marios |
|
2018 |
25 |
C |
p. 46-49 |
artikel |
27 |
Identifying optic neuritis and transverse myelitis using administrative data
|
Marrie, Ruth Ann |
|
2018 |
25 |
C |
p. 258-264 |
artikel |
28 |
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients
|
Ziliotto, Nicole |
|
2018 |
25 |
C |
p. 37-42 |
artikel |
29 |
Influences of pregnancy on neuromyelitis optica spectrum disorders and multiple sclerosis
|
Tong, Yanping |
|
2018 |
25 |
C |
p. 61-65 |
artikel |
30 |
Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination
|
Puthenparampil, M. |
|
2018 |
25 |
C |
p. 241-245 |
artikel |
31 |
Is there an effect of dietary intake on MS-related fatigue? – A systematic literature review
|
Pommerich, Uwe Martin |
|
2018 |
25 |
C |
p. 282-291 |
artikel |
32 |
Key considerations in reimbursement decision-making for multiple sclerosis drugs in Australia
|
Phan, Yen Hoang Le |
|
2018 |
25 |
C |
p. 144-149 |
artikel |
33 |
Lower extremity deep venous thrombosis in a multiple sclerosis patient on dimethyl fumarate
|
Mirmosayyeb, Omid |
|
2018 |
25 |
C |
p. 196 |
artikel |
34 |
Lower frequency of antibodies to MOG in Brazilian patients with demyelinating diseases: An ethnicity influence?
|
Papais-Alvarenga, Regina Maria |
|
2018 |
25 |
C |
p. 87-94 |
artikel |
35 |
Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients
|
Kusumadewi, Winda |
|
2018 |
25 |
C |
p. 329-333 |
artikel |
36 |
Measures of adiposity differentially correlate with C-reactive protein among persons with multiple sclerosis
|
Baynard, Tracy |
|
2018 |
25 |
C |
p. 1-4 |
artikel |
37 |
Metabolomic profile of insulin resistance in patients with multiple sclerosis is associated to the severity of the disease
|
Ruiz-Argüelles, Alejandro |
|
2018 |
25 |
C |
p. 316-321 |
artikel |
38 |
Mining healthcare data for markers of the multiple sclerosis prodrome
|
Högg, Tanja |
|
2018 |
25 |
C |
p. 232-240 |
artikel |
39 |
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder
|
Narayan, Ram |
|
2018 |
25 |
C |
p. 66-72 |
artikel |
40 |
Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: A comparison in different ethnic groups
|
Viswanathan, S |
|
2018 |
25 |
C |
p. 300-308 |
artikel |
41 |
Multiple sclerosis prevalence in Salta City, Argentina
|
Mellinger, S. |
|
2018 |
25 |
C |
p. 212-215 |
artikel |
42 |
Myocardial infarction in a patient with multiple sclerosis after receiving natalizumab
|
Darki, Aala |
|
2018 |
25 |
C |
p. 26-28 |
artikel |
43 |
Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family
|
Gelibter, S |
|
2018 |
25 |
C |
p. 73-76 |
artikel |
44 |
No association between socioeconomic status and risk of multiple sclerosis: A population-based incident case-control study in a developing country
|
Abdollahpour, Ibrahim |
|
2018 |
25 |
C |
p. 292-296 |
artikel |
45 |
No C9orf72 repeat expansion in patients with primary progressive multiple sclerosis
|
Tiloca, Cinzia |
|
2018 |
25 |
C |
p. 192-195 |
artikel |
46 |
Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica
|
Delgado-García, Guillermo |
|
2018 |
25 |
C |
p. 268-270 |
artikel |
47 |
Oligoclonal bands in multiple sclerosis; Functional significance and therapeutic implications. Does the specificity matter?
|
Pryce, Gareth |
|
2018 |
25 |
C |
p. 131-137 |
artikel |
48 |
Outcomes and treatment management of a French cohort suffering from multiple sclerosis: A retrospective epidemiological study
|
Defer, G. |
|
2018 |
25 |
C |
p. 276-281 |
artikel |
49 |
Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders
|
Fragomeni, Manuela de Oliveira |
|
2018 |
25 |
C |
p. 138-142 |
artikel |
50 |
Perceived cognitive deficits and depressive symptoms in patients with multiple sclerosis: Perceived stress and sleep quality as mediators
|
Lamis, Dorian A. |
|
2018 |
25 |
C |
p. 150-155 |
artikel |
51 |
Protective effects of hydro-ethanolic extract of Terminalia chebula on primary microglia cells and their polarization (M1/M2 balance)
|
Rahimi, Vafa Baradaran |
|
2018 |
25 |
C |
p. 5-13 |
artikel |
52 |
Refactory Trigeminal Neuralgia successfully treated by combination therapy (Pregabalin plus Lamotrigine)
|
Solaro, Claudio Marcello |
|
2018 |
25 |
C |
p. 165-166 |
artikel |
53 |
Refining the Nosology of Antigen-Specific Diseases Within the Spectrum of Neuromyelitis Optica
|
Levy, Michael |
|
2018 |
25 |
C |
p. A1-A2 |
artikel |
54 |
Resilience and depression/anxiety symptoms in multiple sclerosis and neuromyelitis optica spectrum disorder
|
Nakazawa, Kanako |
|
2018 |
25 |
C |
p. 309-315 |
artikel |
55 |
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis
|
Naegelin, Y. |
|
2018 |
25 |
C |
p. 14-20 |
artikel |
56 |
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?
|
Barin, Laura |
|
2018 |
25 |
C |
p. 112-121 |
artikel |
57 |
The frequency of dysphagia and its impact on adults with multiple sclerosis based on patient-reported questionnaires
|
Alali, Dalal |
|
2018 |
25 |
C |
p. 227-231 |
artikel |
58 |
The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran
|
Eskandarieh, Sharareh |
|
2018 |
25 |
C |
p. 143 |
artikel |
59 |
The relationship between depression, anxiety and cognition and its paradoxical impact on falls in multiple sclerosis patients
|
Kalron, Alon |
|
2018 |
25 |
C |
p. 167-172 |
artikel |
60 |
Toxic liver injury after high-dose methylprednisolone in people with multiple sclerosis
|
Adamec, Ivan |
|
2018 |
25 |
C |
p. 43-45 |
artikel |
61 |
Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 study
|
Cascione, Mark |
|
2018 |
25 |
C |
p. 50-56 |
artikel |
62 |
Tumefactive multiple sclerosis lesions associated with fingolimod treatment: Report of 5 cases
|
Sánchez, Pedro |
|
2018 |
25 |
C |
p. 95-98 |
artikel |
63 |
Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab
|
Bernard-Valnet, Raphaël |
|
2018 |
25 |
C |
p. 216-218 |
artikel |
64 |
Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: the first five-years
|
Setayeshgar, Solmaz |
|
2018 |
25 |
C |
p. 57-60 |
artikel |
65 |
User testing as a method for evaluating subjects’ understanding of informed consent in clinical trials in multiple sclerosis
|
Ponzio, Michela |
|
2018 |
25 |
C |
p. 108-111 |
artikel |